Acknowledgments
Prematurity, Preeclampsia
PREMATURITY, PREECLAMPSIA
The authors thank the independent Data Monitoring Committee. The authors thank all collaborators at the participant centers and their obstetricians, nurses and midwives involved in trial enrollment and management of patients. The authors thank the supporters of the study. This trial was supported by grants from Bill & Melinda Gates Foundation (OPP1142172) and Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq and the Brazilian Ministry of Health Brazil (401718/2015-8) to M.A.B. Dias. Roche Diagnostics provided the kits for sFlt-1 (soluble fms-like tyrosine kinase-1) and PlGF (placental growth factor) measurement (Elecsys Preeclampsia Platform). The authors thank all patients who participated in the PREPARE trial (Prematurity Reduction by Preeclampsia Care).